U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.629T>C (p.Met210Thr) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Feb 29, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000992058.9

Allele description [Variation Report for NM_000162.5(GCK):c.629T>C (p.Met210Thr)]

NM_000162.5(GCK):c.629T>C (p.Met210Thr)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.629T>C (p.Met210Thr)
Other names:
NM_000162.5(GCK):c.629T>C; p.Met210Thr
HGVS:
  • NC_000007.14:g.44149810A>G
  • NG_008847.2:g.53361T>C
  • NM_000162.5:c.629T>CMANE SELECT
  • NM_001354800.1:c.629T>C
  • NM_033507.3:c.632T>C
  • NM_033508.3:c.626T>C
  • NP_000153.1:p.Met210Thr
  • NP_001341729.1:p.Met210Thr
  • NP_277042.1:p.Met211Thr
  • NP_277043.1:p.Met209Thr
  • LRG_1074t1:c.629T>C
  • LRG_1074t2:c.632T>C
  • LRG_1074:g.53361T>C
  • LRG_1074p1:p.Met210Thr
  • LRG_1074p2:p.Met211Thr
  • NC_000007.13:g.44189409A>G
  • NM_000162.3:c.629T>C
Protein change:
M209T
Links:
dbSNP: rs80356654
NCBI 1000 Genomes Browser:
rs80356654
Molecular consequence:
  • NM_000162.5:c.629T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.629T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.632T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.626T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001144027Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Uncertain significance
(Sep 21, 2018)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

SCV002069117Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 9, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005201998GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Feb 29, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families.

Velho G, Blanché H, Vaxillaire M, Bellanné-Chantelot C, Pardini VC, Timsit J, Passa P, Deschamps I, Robert JJ, Weber IT, Marotta D, Pilkis SJ, Lipkind GM, Bell GI, Froguel P.

Diabetologia. 1997 Feb;40(2):217-24.

PubMed [citation]
PMID:
9049484

Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis.

Davis EA, Cuesta-Muñoz A, Raoul M, Buettger C, Sweet I, Moates M, Magnuson MA, Matschinsky FM.

Diabetologia. 1999 Oct;42(10):1175-86.

PubMed [citation]
PMID:
10525657
See all PubMed Citations (8)

Details of each submission

From Athena Diagnostics, SCV001144027.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV002069117.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV005201998.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate that this variant causes significantly reduced enzyme activity (PMID: 10525657); Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; This variant is associated with the following publications: (PMID: 10525657, 18399931, 27913849, 14517946, 25555642, 9049484)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024